| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 273 | 126 | +116.5% |
| EBITDA | 11.4 | 14.0 | −18.5% |
| EBITDA margin | 4.2% | 11.1% | −6.9 pts |
| Profit before tax | 4.0 | 8.3 | −51.9% |
| Net profit | 3.2 | 5.8 | −43.9% |
| EPS | ₹1.29 | ₹2.31 | −44.2% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 735 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.9 | 2.2 | 4.4 | 2.8 | 1.6 | ||
| 86.5 | 86.5 | 47.0 | 65.1 | 81.2 | ||
| 819 | — | — | — | — | ||
| 854 | 582 | 431 | 328 | 385 | ||
| — | +34.8% | +31.5% | −14.8% | — | ||
| 77.9 | 63.3 | 57.0 | 36.3 | 33.9 | ||
| 9.1% | 10.9% | 13.2% | 11.1% | 8.8% | ||
| 63.0 | 47.5 | 40.3 | 20.6 | 16.3 | ||
| 37.5 | 27.3 | 21.5 | 11.6 | 6.9 | ||
| 4.4% | 4.7% | 5.0% | 3.5% | 1.8% | ||
| ₹15.02 | ₹10.96 | ₹8.63 | ₹4.65 | ₹2.78 | ||
| — | +26.9% | +85.8% | +67.2% | — | ||
| — | −17.8 | 38.0 | 38.4 | 29.9 | ||
| — | 0.0 | 0.0 | −18.9 | −21.9 | ||
| −17.8 | −17.8 | 38.0 | 19.4 | 8.0 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 735.0 | |
| - Cash, Equiv & ST Investments | 1.6 | 2.8 | 4.4 | 2.2 | 2.9 | |
| + Total Debt | 81.2 | 65.1 | 47.0 | 86.5 | 86.5 | |
| Enterprise Value | — | — | — | — | 818.5 | |
| Revenue | 384.7 | 328.0 | 431.3 | 581.6 | 854.4 | |
| Growth %, YoY | — | -14.8 | +31.5 | +34.8 | — | |
| EBITDA | 33.9 | 36.3 | 57.0 | 63.3 | 77.9 | |
| Margin % | 8.82 | 11.06 | 13.22 | 10.88 | 9.12 | |
| EBIT | 16.3 | 20.6 | 40.3 | 47.5 | 63.0 | |
| Net Income | 6.9 | 11.6 | 21.5 | 27.3 | 37.5 | |
| Margin % | 1.80 | 3.53 | 4.99 | 4.70 | 4.38 | |
| EPS, Adj (current shares) | 2.78 | 4.65 | 8.63 | 10.96 | 15.02 | |
| Growth %, YoY | — | +67.2 | +85.8 | +26.9 | — | |
| Cash from Operations | 29.9 | 38.4 | 38.0 | -17.8 | — | |
| Capital Expenditures | -21.9 | -18.9 | -0.0 | -0.0 | — | |
| Free Cash Flow | 8.0 | 19.4 | 38.0 | -17.8 | -17.8 | |
Prices at the previous close · figures from the company's filings with NSE
DMCC SPECIALITY CHEMICALS (NSE: DMCC) had a market capitalisation of ₹735 crore at the previous close (₹294.70 a share), a PE ratio of 19.6 on the last four quarters' profit and a price-to-book ratio of 2.77. In FY26 its consolidated net profit was ₹27.3 crore on revenue of ₹582 crore; in Q2 FY27 (July–September 2026) it was ₹3.2 crore, down 43.9% year on year. Its debt-to-equity ratio was 0.41 on 30 September 2026. Promoters held 53.84% of the shares on 30 September 2026.
DMCC SPECIALITY CHEMICALS's PE ratio is 19.6 at the previous close (₹294.70 a share): a market capitalisation of ₹735 crore divided by consolidated net profit of ₹37.5 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹27.3 crore) it is 26.9.
DMCC SPECIALITY CHEMICALS's net worth — shareholders' equity in its consolidated balance sheet — was ₹265 crore on 30 September 2026, up 13.1% from ₹234 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹735 crore at the previous close.
DMCC SPECIALITY CHEMICALS's book value per share was ₹106.28 on 30 September 2026: shareholders' equity of ₹265 crore divided by the 2.49 crore shares in issue, up 13.1% from ₹93.94 a year earlier. The share price at the previous close was ₹294.70.
DMCC SPECIALITY CHEMICALS's price-to-book (PB) ratio is 2.77 at the previous close: a market capitalisation of ₹735 crore divided by shareholders' equity (book value) of ₹265 crore on 30 September 2026. That is a book value of ₹106.28 per share against a share price of ₹294.70.
In FY26, DMCC SPECIALITY CHEMICALS's return on equity (ROE) was 11.5% and its return on capital employed (ROCE) was 17.0%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.9% and ROCE 14.9%.
DMCC SPECIALITY CHEMICALS's dividend yield is 0.85% at the previous close: dividends of ₹2.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹294.70. They were ₹2.50 on 21 August 2026.
DMCC SPECIALITY CHEMICALS's market capitalisation was ₹735 crore at the previous close: 2.49 crore shares at ₹294.70 each.
No. DMCC SPECIALITY CHEMICALS had borrowings of ₹108 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.41. Its cash and current investments were ₹4.9 crore, so its net debt was ₹103 crore.
DMCC SPECIALITY CHEMICALS's basic earnings per share (EPS) were ₹10.96 in FY26, against ₹8.63 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹15.01.
DMCC SPECIALITY CHEMICALS's debt-to-equity ratio was 0.41 on 30 September 2026: borrowings of ₹108 crore against total equity of ₹265 crore. A year earlier, on 30 September 2025, it was 0.17.
Promoters held 53.84% of DMCC SPECIALITY CHEMICALS on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, DMCC SPECIALITY CHEMICALS generated ₹17.8 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹17.8 crore. In FY25 it was ₹38 crore.
In 2026, DMCC SPECIALITY CHEMICALS has declared one dividend: ₹2.50 with record date 21 August 2026.
DMCC SPECIALITY CHEMICALS's latest results are for Q2 FY27 (July–September 2026), filed on 30 October 2026: consolidated net profit ₹3.2 crore, down 43.9% from ₹5.8 crore in Q2 FY26; revenue from operations ₹273 crore, up 116.5% year on year.
In FY26 (April 2025–March 2026), DMCC SPECIALITY CHEMICALS's consolidated net profit was ₹27.3 crore, up 26.9% from ₹21.5 crore in FY25, on revenue from operations of ₹582 crore (up 34.8%). Over three years, from FY23, net profit was up 294.3%.
On 30 September 2026, DMCC SPECIALITY CHEMICALS's shares were held by promoters 53.84%, foreign portfolio investors (FII/FPI) 0.54%, domestic institutions (DII) 1.26% (including mutual funds at 0.01%) and retail and other non-institutional investors 44.36%. Over the year, FII holding was up 0.15 percentage points from 0.39% and DII holding was down 0.02 percentage points from 1.28%.
DMCC SPECIALITY CHEMICALS has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
In FY26, DMCC SPECIALITY CHEMICALS earned net profit of ₹27.3 crore on revenue of ₹582 crore, against ₹50.4 crore on ₹2,406 crore for Jayant Agro Organics. DMCC SPECIALITY CHEMICALS's operating margin was 8.2% (Jayant Agro Organics 3.4%) and its return on equity 11.5% (Jayant Agro Organics 8.5%).
On FY26 consolidated figures, against Jayant Agro Organics, Kronox Lab Sciences and Sree Rayalaseema Hi-Strength Hypo: DMCC SPECIALITY CHEMICALS's operating margin of 8.2% is the third highest of the four (Jayant Agro Organics 3.4%, Kronox Lab Sciences 31.8%, Sree Rayalaseema Hi-Strength Hypo 12.2%; peer average 15.8%); its return on equity of 11.5% is the second highest of the four (Jayant Agro Organics 8.5%, Kronox Lab Sciences 26.8%, Sree Rayalaseema Hi-Strength Hypo 9.5%; peer average 15.0%).
From DMCC SPECIALITY CHEMICALS's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.